Nu Holdings Ltd. (NU) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Nu Holdings Ltd. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 14, 2026. Differences are shown without an overall score or investment verdict.

Compare
Different business models: NU is classified in Financial Services; OSCR is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

Total returnNU vs OSCR

growth of $100 · dividends reinvested · last 5y
NU +34.8% (+6.2%/yr)OSCR +215.4% (+25.8%/yr)OSCR compounded faster over this window
0100200300Start $10020222023202420252026$135$315
NU OSCR

NU vs OSCR: by the numbers

  • NU is the larger company ($73.76B vs $8.49B market cap).
  • NU trades at the lower trailing earnings multiple (21.43 vs 21.99 P/E), one valuation lens rather than an overall verdict.
  • NU converts more revenue to profit (18.15% vs 3.60% net margin).
  • NU grew revenue faster over the past five years (98.88% vs 64.83% CAGR).

Metrics side by side

Valuation

MetricNUOSCR
P/E ratio21.4321.99
Forward P/E16.5027.88
P/S ratio3.900.67
P/B ratio5.435.00
EV / EBITDAN/A10.15
FCF yieldN/A42.19%

Profitability

MetricNUOSCR
Gross margin43.74%14.38%
Operating margin22.96%4.07%
Net margin18.15%3.60%
ROE25.29%26.84%

Growth (annualized)

MetricNUOSCR
Revenue CAGR (5Y)98.88%64.83%
FCF CAGR (5Y)N/A80.81%
Total return CAGR (5Y)N/A15.93%

Frequently asked

Which has the lower trailing P/E, NU or OSCR?
NU has the lower trailing P/E: NU trades at 21.43 and OSCR at 21.99. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, NU or OSCR?
Over the past five years, NU grew revenue faster — NU at a 98.88% CAGR versus OSCR at 64.83%.
Is NU or OSCR more profitable?
NU runs the higher net margin — NU at 18.15% versus OSCR at 3.60%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 14, 2026.